author-photo

A. O’Neill

Harvard University

14

Papers

1106

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Abstract GS6-03: Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II-III breast cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (12)
Randomized phase II trial of gefitinib plus anastrozole or fulvestrant in postmenopausal, metastatic breast cancer

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

2014
Show All
- Source
- Cite
- Save
Citations (0)
Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts

2013 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (26)
Plasma angiopoietin-2 (ANG2) as an angiogenic biomarker in renal cell carcinoma (RCC).

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (26)
Phase II feasibility trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node-positive breast cancer: A trial of the Eastern Cooperative Oncology Group (E2104)

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (40)
Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion

2005 Cancer Research
Show All
- Source
- Cite
- Save
Citations (717)
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI

1998 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (201)